Skip to content

A randomized controlled trial study on the effectiveness of 17 alpha hydroxyprogesterone and micronised progesterone in preventing preterm labor of pregnant women with arrested premature labor.

A randomized controlled trial study on the effectiveness of 17 alpha hydroxyprogesterone and micronised progesterone in preventing preterm labor of pregnant women with arrested premature labor.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210407003
Enrollment
48
Registered
2021-04-07
Start date
2019-06-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnant women with arrested premature labor gestational age 24-33+6 week pregnant women with arrested premature labor, 17 alpha hydroxyprogesterone, micronised progesterone

Interventions

Participants were given a micronised progesterone 200 mg vaginal suppository once a day before bedtime by herself. Until 36 + 6 weeks gestation, or stop the drug if delivered before,Participants were
micronised progesterone, 17 alpha hydroxyprogesterone and micronised progesterone,Standard Care

Sponsors

Faculty of medicine Mahasarakham university
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Pregnant women with arrested premature labor gestational age 24-33+6 week, > 18 years old, 2. Have been examined ultrasound to confirm gestational age and confirm no anormaly., 3. Cervical dilatation < 4 cms.

Exclusion criteria

Exclusion criteria: 1. Pregnant woman who had contraindication to inhibit preterm labor, such as chorioamnionitis 2. Membrane leak or rupture 3. Allergy to any component of progesterone 4. Mothers with severe obstetrical or medical complications sush as severe preeclampsia

Design outcomes

Primary

MeasureTime frame
preterm delivery at delivery time Patient reported outcome using a questionaire

Secondary

MeasureTime frame
duration to prolong pregnancy period at delivery time Patient reported outcome using a questionnaire interview

Countries

Thailand

Contacts

Public ContactTeabpaluck Sirithanawuthuchai

Faculty of medicine, Mahasarakham university

teabpaluck.i@msu.ac.th0898635745

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026